United States · FDA National Drug Code directory
MYTESI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70564-802_f9b7d7cd-31ef-4030-ae3f-10ab635d0758
- Product NDC
- 70564-802
- Form
- TABLET, COATED
- Composition / generic term
- Crofelemer
- Labeler
- Napo Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160801
- Source listing expiry
- 20271231
Source-listed ingredients
- CROFELEMER — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, COATED in 1 BOTTLE (70564-802-60) · 70564-802-60
- 60 TABLET, COATED in 1 BOTTLE (70564-802-99) · 70564-802-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →